GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Contineum Therapeutics Inc (NAS:CTNM) » Definitions » Other Gross PPE

Contineum Therapeutics (Contineum Therapeutics) Other Gross PPE : $1.23 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Contineum Therapeutics Other Gross PPE?

Contineum Therapeutics's Other Gross PPE for the quarter that ended in Mar. 2024 was $1.23 Mil.

Contineum Therapeutics's quarterly Other Gross PPE increased from Sep. 2023 ($2.74 Mil) to Dec. 2023 ($2.82 Mil) but then declined from Dec. 2023 ($2.82 Mil) to Mar. 2024 ($1.23 Mil).

Contineum Therapeutics's annual Other Gross PPE increased from Dec. 2021 ($1.57 Mil) to Dec. 2022 ($3.37 Mil) but then declined from Dec. 2022 ($3.37 Mil) to Dec. 2023 ($2.82 Mil).

Contineum Therapeutics Other Gross PPE Historical Data

The historical data trend for Contineum Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Contineum Therapeutics Other Gross PPE Chart

Contineum Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Other Gross PPE
1.57 3.37 2.82

Contineum Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial 3.37 - 2.74 2.82 1.23

Contineum Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Contineum Therapeutics (Contineum Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Contineum Therapeutics Inc (NAS:CTNM) » Definitions » Other Gross PPE
Comparable Companies
Traded in Other Exchanges
N/A
Address
10578 Science Center Drive, Suite 200, San Diego, CA, USA, 92121
Website
https://www.contineum-tx.com
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Contineum Therapeutics (Contineum Therapeutics) Headlines

From GuruFocus

Contineum Therapeutics Announces Pricing of Initial Public Offering

By GlobeNewswire • 04-05-2024